CMHC Chairpersons Christie M. Ballantyne, MD, Robert H. Eckel, MD, Anne L. Peters, MD, and George L. Bakris, MD invite you to submit scientific poster abstracts to be presented at the 2020 Virtual Cardiometabolic Health Congress (CMHC), October 21-24, 2020. Plan now to have your poster included! Your poster will be included in the meeting as an electronic poster (ePoster). Your abstract and poster will be listed on the CMHC website (access restricted only to registered Annual attendees) and will be published online on the journal Medical Sciences. Do not miss your chance to showcase your research at the largest US-based, multidisciplinary conference addressing the full spectrum of cardiometabolic disease prevention and management. Abstracts may be research-oriented or evidence-based practice that are relevant to frontline practitioners who treat patients with cardiometabolic disease.

Best Poster Award:

At the 15th Annual Cardiometabolic Health Congress (CMHC), the scientific committee will select the best scientific poster abstract based on ingenuity and content. The winning presenter will be awarded a prize of $300, sponsored by Medical Sciences, an international open access journal providing a platform for advances in basic, translational, and clinical research.

Chance to Publish Full Papers Free of Charge:

Authors that have an abstract accepted at 2020 Virtual CMHC will have a chance to submit full scientific papers based on the work presented free of charge. Scientific papers will be published online on the peer-reviewed journal Medical Sciences pending appropriate peer review. More details can be found here.

*EXTENDED* Deadline:

  • UPDATED: Submissions have been extended to Friday, September 25, 2020
  • UPDATED: Notification of abstract status is now Friday, October 2, 2020

Abstract Guidelines:

  1. Presenting author(s) or presenter(s) of accepted abstracts must register for the Virtual 2020 Annual CMHC. If your abstract is accepted, you will receive an exclusive link for a reduced meeting registration rate (50% off). Submission of an abstract does not automatically register you for the conference.
  2. Abstracts may be of original research or encore (repeat) presentations of abstracts, i.e., CMHC will accept abstracts that have already been presented at other medical conferences.
  3. Abstracts should be 900 words or less, with maximums as defined below. (Titles, author names, and affiliations are not included in the word count).
    • Purpose: 250 words
    • Methods: 250 words
    • Results: 300 words
    • Conclusions: 300 words
  4. List affiliations for all authors, such as universities and other institutions.
  5. List names of all authors, in the order in which you wish them to appear in printed text. One author listed must be registered for the virtual meeting. No more than 10 authors should be listed.
  6. List disclosures (financial and/or in-kind support). If none, state “Nothing to disclose by any author(s).”
  7. Do not use tables, charts, or graphs in your abstract submission (they can be included in the actual poster).
  8. There is no limit to the number of abstracts one author may submit for consideration.
  9. The first author is responsible for communicating all of these policies to all involved parties.

Disclosure:

CMHC requires faculty and poster authors/presenters who have an interest in selling a technology, program, product, and/or service to healthcare professionals to disclose this information in order to be considered for and/or present at any CMHC educational session.

Publication:

If your abstract is accepted, you will be notified on or by Friday, September 4, 2020, and the abstracts will be posted on the CMHC website by September 27, 2020. Only accepted abstracts will be posted online. Posters will be published within the CMHC website and in the journal, Medical Sciences following the Congress.

Poster and Presentation Guidelines:

  1. Detailed instructions will accompany acceptance notices.
  2. After acceptance, format your abstract into a poster which may include graphs, tables, and charts.
  3. ePosters should be in PDF or Powerpoint format.
  4. 16:9 is the preferred aspect ratio.
  5. PowerPoint-specific features such as animations, page transitions, hyperlinks, or embedded video or audio are not supported.
  6. No trade names should be used for drugs, devices, or instrumentation. Any medications or substances referred to in the materials must be identified by their scientific names only.
  7. QR codes with a maximum size of 1”x1” are permitted in the lower corner of posters. Scanning of a QR code only by participants using smart phones or other mobile devices is permissible.
  8. Supplementary information on how to download relevant QR codes and access interactive content may be included on the poster, ie, within the text of the poster or printed on the bottom.

Presentation Time:

There will not be a set presentation time. All ePosters will be available during the virtual meeting starting Wednesday, October 21, 2020 at 1:15PM EST.

Late-breaking Abstracts:

The CMHC late-breaking abstracts policy allows for the submission of late-breaking abstracts only for randomized phase II and phase III trials for which no preliminary data are available at the time of the abstract submission deadline (September 25, 2020), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before September 20, 2020 (deadline for the final, updated late-breaking abstract). During abstract submission, you will be required to provide the date of planned analysis. The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline. Late-breaking abstracts must follow the same abstract guidelines listed on this page.

Submission:

Click HERE to submit an abstract. The abstract system will close at 5:00PM EST, September 25, 2020.